List of Treatments for Myeloproliferative Neoplasms

Gleevec (Imatinib Mesylate)

Overview
Gleevec is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults and children with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) — a type of … read more

Inrebic (Fedratinib)

Overview
Inrebic is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with intermediate or high-risk primary or secondary myelofibrosis, a cancer of the bone marrow. Inrebic is… read more

Jakafi (Ruxolitinib)

Overview
Jakafi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera… read more

Ojjaara (Momelotinib)

Overview
Ojjaara is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with myelofibrosis (MF) and anemia (low red blood cell count). Ojjaara may be recommended to treat… read more

Sprycel (Dasatinib)

Overview
Sprycel is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with:
• Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia… read more

Tasigna (Nilotinib)

Overview
Tasigna is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) — a type of myeloproliferative… read more

Vonjo (Pacritinib)

Overview
Vonjo is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with certain types of myelofibrosis. Vonjo is also known by its generic name, pacritinib.

Vonjo is… read more